Zobrazeno 1 - 9
of 9
pro vyhledávání: '"M A Kanonirova"'
Autor:
I G Kirillova, D S Novikova, T V Popkova, E N Aleksandrova, A A Novikov, Yu N Gorbunova, E I Markelova, Yu O Korsakova, S I Glukhova, A V Volkov, E L Luchikhina, N V Demidova, K A Kasumova, S A Vladimirov, M A Kanonirova, G L Lukina, D E Karateev, E L Nasonov
Publikováno v:
Терапевтический архив, Vol 88, Iss 5, Pp 19-26 (2016)
Aim. To determine N-terminal pro-brain natriuretic peptide (NT-proBNP) levels in patients with early rheumatoid arthritis (RA) before the use of disease-modifying antirheumatic drugs (DMARDs); to compare NT-proBNP values with traditional risk factors
Externí odkaz:
https://doaj.org/article/f7c1e68a78364be78a49b432ab41d573
Autor:
E. L. Luchikhina, D. E. Karateev, N. V. Demidova, G. S. Gridneva, G. V. Lukina, M. A. Kanonirova, Yu. V. Muravyev, K. A. Kasumova, E. N. Aleksandrova, A. А. Novikov, A. S. Avdeeva
Publikováno v:
Современная ревматология, Vol 10, Iss 4, Pp 16-20 (2016)
Russian and international clinical recommendations postulate the possibility of withdrawal of biological agents in patients with rheumatoid arthritis (RA) after the achievement of clinical remission. But it is not clear what would be the results of i
Externí odkaz:
https://doaj.org/article/fe1534d18dd542deb63e84d07ba2ba99
Autor:
I. G. Kirillova, D. S. Novikova, T. V. Popkova, Yu. N. Gorbunova, E. I. Markelova, Yu. O. Korsakova, O. A. Fomicheva, A. V. Volkov, E. L. Luchikhina, N. V. Demidova, K. A. Kasumova, S. A. Vladimirov, M. A. Kanonirova, G. L. Lukina, A. A. Novikov, E. N. Aleksandrova, D. E. Karateev, E. L. Nasonov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 11, Iss 4, Pp 398-403 (2015)
Aim. To study the effect of «treat-to-target» antirheumatic therapy on diastolic dysfunction of the left (DDLV) and right (DDLV) ventricles in patients with early rheumatoid arthritis (RA) during 18 months of observation.Material and methods. The s
Externí odkaz:
https://doaj.org/article/0b4c84d45f804c7b95ec2d0f589c8249
Autor:
D. E. Karateev, E. L. Luchikhina, N. V. Demidova, G. S. Gridneva, G. V. Lukina, M. A. Kanonirova, Yu. V. Muravyev, K. A. Kasumova, E. N. Aleksandrova, A. A. Novikov, A. S. Avdeeva, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 54, Iss 2, Pp 138-144 (2016)
The early administration of methotrexate (MTX) and the use of its high (by the rheumatology practice standards) doses contribute to the enhanced efficiency of therapy and the reduced severity of rheumatoid arthritis (RA). One of the important merits
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de23f6fd25787a0062d0ee3ab3dacb3d
https://rsp.mediar-press.net/rsp/article/view/2202
https://rsp.mediar-press.net/rsp/article/view/2202
Autor:
E. V. Udachkina, D. S. Novikova, T. V. Popkova, I. G. Kirillova, Yu. N. Gorbunova, E. I. Markelova, D. E. Karateev, E. L. Luchikhina, A. A. Novikov, E. N. Aleksandrova, N. V. Demidova, M. A. Kanonirova, G. V. Lukina, A. V. Volkov, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 54, Iss 2, Pp 164-170 (2016)
The mechanisms for lowering a cardiovascular risk (CVR) in patients with early rheumatoid arthritis (RA) when implementing the treat-to-target strategy remain inadequately investigated.Objective: to estimate the time course of changes in blood lipid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afa027c704a8433b9c07087c251a6546
https://doi.org/10.14412/1995-4484-2016-164-170
https://doi.org/10.14412/1995-4484-2016-164-170
Autor:
Yu. O. Korsakova, Nasonov El, N. V. Demidova, Novikov Aa, E. L. Luchikhina, G. L. Lukina, Tatiana Popkova, D. S. Novikova, Yu. N. Gorbunova, Svetlana Glukhova, E. Markelova, I. Kirillova, Dmitry Karateev, Aleksandrova En, M. A. Kanonirova, S. A. Vladimirov, Alexander Volkov, K. A. Kasumova
Publikováno v:
Терапевтический архив, Vol 88, Iss 5, Pp 19-26 (2016)
To determine N-terminal pro-brain natriuretic peptide (NT-proBNP) levels in patients with early rheumatoid arthritis (RA) before the use of disease-modifying antirheumatic drugs (DMARDs); to compare NT-proBNP values with traditional risk factors (TRF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b47af2811f9a44b8a6897d884d1e2d8e
https://doi.org/10.17116/terarkh201688519-26
https://doi.org/10.17116/terarkh201688519-26
Autor:
D. E. Karatee, E. L. Luchikhina, N. V. Demidova, G. S. Gridneva, M. A. Kanonirova, Yu. V. Muravyev, G. V. Lukina, Yu. A. Olyunin, K. A. Kasumova, E. N. Aleksandrova, A. A. Novikov, A. A. Avdeeva, T. V. Popkova, D. S. Novikova, A. V. Smirnov, A. V. Volkov, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 54, Iss 0, Pp 63-70 (2016)
To introduce treat-to-target recommendations is an important task of modern rheumatology; however, there is still a diversity of serious problems relating to a scientific rationale and a clinical one for this strategy and to the possibilitiesof its i
Externí odkaz:
https://doaj.org/article/3773a539755a49228e183a3bd034c72a
Autor:
D. E. Karateev, E. L. Luchikhina, N. V. Demidova, G. S. Gridneva, M. A. Kanonirova, Yu. V. Muravyev, G. V. Lukina, Yu. A. Olyunin, K. A. Kasumova, E. N. Aleksandrova, A. A. Novikov, A. A. Avdeeva, T. V. Popkova, D. S. Novikova, A. V. Smirnov, A. V. Volkov, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 53, Iss 5s, Pp 77-84 (2015)
To introduce treat-to-target recommendations is an important task of modern rheumatology; however, there is still a diversity of serious problems relating to a scientific rationale and a clinical one for this strategy and to the possibilities of its
Externí odkaz:
https://doaj.org/article/940c226357df4076bb9fe77ee1820a97
Autor:
D. E. Karateev, E. L. Luchikhina, N. V. Demidova, G. S. Gridneva, M. A. Kanonirova, Yu. V. Muravyev, G. V. Lukina, Yu. A. Olyunin, K. A. Kasumova, E. N. Aleksandrova, A. A. Novikov, A. A. Avdeeva, T. V. Popkova, D. S. Novikova, A. V. Smirnov, A. V. Volkov, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 52, Iss 6, Pp 607-614 (2014)
To introduce treat-to-target recommendations is an important task of modern rheumatology; however, there is still a diversity of serious problems relating to a scientific rationale and a clinical one for this strategy and to the possibilities of its
Externí odkaz:
https://doaj.org/article/00e73b423915499a83f80a1ba8e7fcd2